These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Side effects of 5-aminosalicylic acid]. Marteau P, Cellier C. Gastroenterol Clin Biol; 1997 Dec 17; 21(5):377-86. PubMed ID: 9208013 [No Abstract] [Full Text] [Related]
3. Methaemoglobinaemia and renal failure following mesalazine for treatment of inflammatory bowel disease. Druez A, Rahier JF, Hébuterne X. J Crohns Colitis; 2014 Aug 17; 8(8):900-1. PubMed ID: 24486176 [No Abstract] [Full Text] [Related]
4. [The treatment of inflammatory intestinal diseases with preparations of 5-aminosalicylic acid]. Frol'kis AV. Ter Arkh; 1996 Aug 17; 68(2):75-7. PubMed ID: 8771669 [No Abstract] [Full Text] [Related]
5. [Pentasa (mesalazine) and pregnancy]. Jonville-Bera AP, Soyez C, Fignon A, Moraine C, Berger C, Autret E. Therapie; 1994 Aug 17; 49(5):443-5. PubMed ID: 7855761 [Abstract] [Full Text] [Related]
6. Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature. Sviri S, Gafanovich I, Kramer MR, Tsvang E, Ben-Chetrit E. J Clin Gastroenterol; 1997 Jan 17; 24(1):34-6. PubMed ID: 9013348 [Abstract] [Full Text] [Related]
7. [Mesalazine]. Netzer P. Dtsch Med Wochenschr; 1996 Jan 05; 121(1-2):42. PubMed ID: 8565806 [No Abstract] [Full Text] [Related]
17. The Association of Mesalamine With Kidney Disease. Adiga A, Goldfarb DS. Adv Chronic Kidney Dis; 2020 Jan 05; 27(1):72-76. PubMed ID: 32147005 [Abstract] [Full Text] [Related]